EP
DGX icon

Essential Partners’s Quest Diagnostics DGX Stock Holding History

Essential Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.63K Hold
7
– – ﹤0.01% 1995
2026
Q2 		$1.48K Hold
7
– – ﹤0.01% 2089
2026
Q1 		$1.37K Buy
7
+3
+75% +$583 ﹤0.01% 2135
2025
Q4 		$694 Hold
4
– – ﹤0.01% 2146
2025
Q3 		$762 Hold
4
– – ﹤0.01% 2098
2025
Q2 		$719 Buy
+4
New +$695 ﹤0.01% 1592

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.13B AUM 26% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Essential Partners's DGX Position: Q3 2026 in Review

Essential Partners held its Quest Diagnostics (DGX) position steady in Q3 2026 at 7 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1995.

Essential Partners first reported a position in DGX in Q2 2025 and has held it in 6 quarters since. 88 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Essential Partners held 7 shares of Quest Diagnostics worth $1.63K as of Q3 2026.
  • Essential Partners left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1995 holding.
  • Essential Partners first reported a position in Quest Diagnostics in Q2 2025 and has held it in 6 quarters since.
  • 88 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.